Markets:

Overview

News

Currencies

International

Treasuries

Arm Holdings plc - American Depositary Shares (NQ:ARM)

202.69 +5.90 (+3.00%)

Delayed Quote Updated: 1:45 PM EST, Nov 3, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Arm Holdings plc - American Depositary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Market Today: Marvell’s $115 Billion Bet on Lumentum Backfires as Chip Stocks Drag the Nasdaq Lower ↗

Today 8:01 EST

Via Chartmill

Why Arm Holdings Stock Lost 29% Last Month ↗

November 02, 2026

Chip stocks walloped on concerns about CoreWeave

Via The Motley Fool

Topics Artificial Intelligence Bonds

Is Amazon Stock a Buy as Cloud Revenue Continues to Surge? ↗

November 02, 2026

Amazon's cloud computing revenue continues to accelerate.

Via The Motley Fool

Topics Artificial Intelligence

Church & Dwight: 3 Key Takeaways for Long-Term Investors ↗

November 01, 2026

Personal care market share gains and value-tier momentum show how the company is winning across consumer segments despite industry headwinds.

Via The Motley Fool

Topics Earnings Economy

The 5 most interesting analyst questions from Church & Dwight’s Q3 earnings call

November 01, 2026

Church & Dwight’s third quarter results were driven by broad-based organic growth across its core product categories and a strong showing from its power bran...

Via StockStory

Topics Earnings Economy

Church & Dwight (CHD) Q3 2026 Earnings Call Transcript ↗

October 31, 2026

Organic sales beat guidance at 5.1% as volume gains offset inflation.

Via The Motley Fool

Topics Earnings Economy

Rocket Lab's Backlog Is $2.36 Billion -- More Than Double Its 2026 Revenue -- and the Stock Still Fell 38% This Month. Here's the Disconnect. ↗

October 31, 2026

Investors had to know this day was coming sooner or later.

Via The Motley Fool

Amazon: 3 Key Takeaways for Long-Term Investors ↗

October 31, 2026

Capital spending is accelerating, but retail margins are expanding simultaneously, a rare combination that tests whether Amazon can sustain profitability through its AI buildout.

Via The Motley Fool

Topics Artificial Intelligence Earnings

CHD Q3 deep dive: innovation, productivity, and brand strength shape outlook amid inflationary pressures

October 31, 2026

Household products company Church & Dwight (NYSE:CHD) reported Q3 2026 results beating Wall Street’s revenue expectations, with sales up 1% year on year to $...

Via StockStory

Topics Economy

Intel Drags Down CPU Rivals. Is it a Buying Opportunity for AMD and Arm? ↗

October 30, 2026

CPUs still have a lot of growth potential even with weakness in PCs.

Via The Motley Fool

Topics Artificial Intelligence ETFs

Why Arm Holdings Stock Plummeted by Nearly 10% Today ↗

October 30, 2026

We can call it "The Intel Effect."

Via The Motley Fool

Topics Artificial Intelligence

Church & Dwight Q3 Earnings Call Highlights ↗

October 30, 2026

Church & Dwight (NYSE:CHD) reported third-quarter results that exceeded its prior outlook, led by volume growth, innovation and broad-based gains across its domestic, international and specialty...

Via MarketBeat

Topics ETFs Earnings Economy

Zenas BioPharma Eyes Key Lupus and IL-17 Data as Obexelimab FDA Decision Nears ↗

October 30, 2026

Zenas BioPharma (NASDAQ:ZBIO) outlined development plans for obexelimab in systemic lupus erythematosus (SLE) and ZB021, an investigational oral IL-17AA/AF inhibitor, during an R&D event ahead of...

Via MarketBeat

Boot Barn: 3 Key Takeaways for Long-Term Investors ↗

October 29, 2026

New stores are outperforming by $200,000 per location while sourcing gains protect margins, creating a dual growth engine.

Via The Motley Fool

Topics Earnings

Wall Street Has Written Off Lennar. Here's Why That's a Mistake. ↗

October 29, 2026

The stock has struggled due to the bad housing market.

Via The Motley Fool

Topics Economy

Prediction: Palantir Stock Will Skyrocket After Nov. 2 ↗

October 28, 2026

Palantir has rallied impressively in recent months, and its upcoming report could give the stock another boost.

Via The Motley Fool

Topics Artificial Intelligence Earnings

What's Wrong With Comcast Stock? ↗

October 28, 2026

It's starting to feel like this ticker might never stop falling.

Via The Motley Fool

Here's What $10,000 Invested in SpaceX Could Be Worth in 2030 ↗

October 28, 2026

SpaceX's growth is impressive, but its valuation leaves little room for disappointment.

Via The Motley Fool

Topics Artificial Intelligence

Why Alphabet’s Own AI Chips May Be Its Quietest Advantage ↗

October 28, 2026

Alphabet’s chip business is just starting to contribute to results.

Via The Motley Fool

Topics Artificial Intelligence

Nvidia Stock Is 10% Below Its Record. Does Anthropic's IPO Filing Make It a Buy? ↗

October 27, 2026

How much of the Claude maker's rent goes to the chip giant?

Via The Motley Fool

Topics Initial Public Offering

Arm vs. Western Digital: Which Tech Stock Is the Better Buy in November? ↗

October 27, 2026

Arm commands premium valuations on its licensing dominance, while Western Digital trades at a steep discount due to the industry's cyclical nature.

Via The Motley Fool

Topics Artificial Intelligence

JPMorgan Chase Says That Bitcoin Will Outperform Stocks, Bonds, and Gold Over the Next 10 Years. Here's Why It Might Be Right ↗

October 27, 2026

The banking giant is still pretty skeptical about Bitcoin.

Via The Motley Fool

Topics Bonds Economy

Brazil Stocks Plunged. Should You Buy the Dip in MercadoLibre? ↗

October 27, 2026

Brazil stocks tumbled on election news, though not much is changing after the result.

Via The Motley Fool

Topics ETFs Economy

Bristol Myers Squibb’s Cancer Drug Just Doubled Survival Time Without Progression — Here’s Why It Matters ↗

October 27, 2026

The medication, which is being developed with the company's Chinese partner, did very well in a late-stage clinical trial.

Via The Motley Fool

AstraZeneca Highlights Breakthrough Cancer Data at ESMO 2026 Investor Update ↗

October 26, 2026

Astrazeneca (NYSE:AZN) highlighted new clinical data across bladder, lung and gastric cancers at its ESMO 2026 investor event, including four presidential presentations that executives said support the...

Via MarketBeat

Topics ETFs

Xencor Picks Phase 3 Dose After XmAb819 Shows 45.5% Response Rate in Kidney Cancer ↗

October 26, 2026

Xencor (NASDAQ:XNCR) reported updated Phase 1 dose-expansion results for its ENPP3-targeting CD3 T-cell engager, XmAb819, in previously treated advanced clear cell renal cell carcinoma at the ESMO 2026...

Via MarketBeat

Dogecoin Is Finally Getting Serious About Offering Real Utility to Users. Here's What That Could Mean for the Price of DOGE. ↗

October 26, 2026

Dogecoin Labs aims to make the world's first meme coin more useful.

Via The Motley Fool

Topics Intellectual Property

Eni: 3 Key Takeaways for Long-Term Investors ↗

October 26, 2026

The satellite business model lets Eni expand clean energy without straining core capital allocation.

Via The Motley Fool

Topics Earnings

Elon Musk and SpaceX Just Delivered Incredible News to Nvidia That Could Help the Stock Double in the Next Year ↗

October 26, 2026

SpaceX's AI spending plans could translate into $400 billion in revenue for Nvidia next year.

Via The Motley Fool

Topics Artificial Intelligence Earnings

Can GE Vernova's Gas Turbines Make Up for a Collapsing Wind Business? ↗

October 25, 2026

It's a red flag investors would rather not see waving, but most of them may not have put this shift in its proper perspective.

Via The Motley Fool

Topics Energy

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.